Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Transforming growth factor beta receptor type 3 (TGF-beta receptor type 3) (TGFR-3) (Betaglycan) (Transforming growth factor beta receptor III) (TGF-beta receptor type III)

 TGBR3_HUMAN             Reviewed;         851 AA.
Q03167; A0AUW8; A8K5N0; B9EG88; Q5T2T4; Q5U731; Q9UGI2;
01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
02-NOV-2010, sequence version 3.
10-OCT-2018, entry version 165.
RecName: Full=Transforming growth factor beta receptor type 3;
Short=TGF-beta receptor type 3;
Short=TGFR-3;
AltName: Full=Betaglycan;
AltName: Full=Transforming growth factor beta receptor III;
Short=TGF-beta receptor type III;
Flags: Precursor;
Name=TGFBR3;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT PHE-15.
TISSUE=Placenta;
PubMed=1333192; DOI=10.1016/0006-291X(92)91566-9;
Moren A., Ichijo H., Miyazono K.;
"Molecular cloning and characterization of the human and porcine
transforming growth factor-beta type III receptors.";
Biochem. Biophys. Res. Commun. 189:356-362(1992).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT PHE-15.
TISSUE=Blood;
PubMed=10944857; DOI=10.1007/s100380070035;
Zippert R., Baessler A., Holmer S.R., Hengstenberg C., Schunkert H.;
"Eleven single nucleotide polymorphisms and one triple nucleotide
insertion of the human TGF-beta III receptor gene.";
J. Hum. Genet. 45:250-253(2000).
[3]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ASN-14; PHE-15;
LEU-163; THR-635 AND ARG-765.
NIEHS SNPs program;
Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Tongue;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=16710414; DOI=10.1038/nature04727;
Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
Beck S., Rogers J., Bentley D.R.;
"The DNA sequence and biological annotation of human chromosome 1.";
Nature 441:315-321(2006).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Brain;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[7]
INTERACTION WITH TCTEX1D4.
PubMed=16982625; DOI=10.1074/jbc.M608614200;
Meng Q.-J., Lux A., Holloschi A., Li J., Hughes J.M.X., Foerg T.,
McCarthy J.E.G., Heagerty A.M., Kioschis P., Hafner M., Garland J.M.;
"Identification of Tctex2beta, a novel dynein light chain family
member that interacts with different transforming growth factor-beta
receptors.";
J. Biol. Chem. 281:37069-37080(2006).
-!- FUNCTION: Binds to TGF-beta. Could be involved in capturing and
retaining TGF-beta for presentation to the signaling receptors.
-!- SUBUNIT: Interacts with TCTEX1D4. {ECO:0000269|PubMed:16982625}.
-!- INTERACTION:
O14908:GIPC1; NbExp=3; IntAct=EBI-2852679, EBI-373132;
P01137:TGFB1; NbExp=2; IntAct=EBI-2852679, EBI-779636;
-!- SUBCELLULAR LOCATION: Secreted. Secreted, extracellular space.
Cell membrane {ECO:0000305}; Single-pass type I membrane protein
{ECO:0000305}. Note=Exists both as a membrane-bound form and as
soluble form in serum and in the extracellular matrix.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=2;
Name=1;
IsoId=Q03167-1; Sequence=Displayed;
Name=2;
IsoId=Q03167-2; Sequence=VSP_040018;
-!- PTM: Extensively modified by glycosaminoglycan groups (GAG).
-!- SEQUENCE CAUTION:
Sequence=AAA67061.1; Type=Frameshift; Positions=70, 73, 349, 350; Evidence={ECO:0000305};
-!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
and Haematology;
URL="http://atlasgeneticsoncology.org/Genes/TGFBR3ID42541ch1p33.html";
-!- WEB RESOURCE: Name=NIEHS-SNPs;
URL="http://egp.gs.washington.edu/data/tgfbr3/";
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; L07594; AAA67061.1; ALT_FRAME; mRNA.
EMBL; AJ251961; CAB64374.1; -; mRNA.
EMBL; AY796304; AAV50003.1; -; Genomic_DNA.
EMBL; AK291345; BAF84034.1; -; mRNA.
EMBL; AC099334; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AL162263; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AL390780; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AL445992; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BC126116; AAI26117.1; -; mRNA.
EMBL; BC136295; AAI36296.1; -; mRNA.
CCDS; CCDS30770.1; -. [Q03167-1]
CCDS; CCDS55614.1; -. [Q03167-2]
PIR; JC1350; JC1350.
RefSeq; NP_001182612.1; NM_001195683.1. [Q03167-2]
RefSeq; NP_001182613.1; NM_001195684.1. [Q03167-2]
RefSeq; NP_003234.2; NM_003243.4. [Q03167-1]
RefSeq; XP_006710930.1; XM_006710867.2. [Q03167-1]
RefSeq; XP_006710931.1; XM_006710868.2.
UniGene; Hs.482390; -.
UniGene; Hs.735919; -.
ProteinModelPortal; Q03167; -.
SMR; Q03167; -.
BioGrid; 112907; 27.
DIP; DIP-5940N; -.
IntAct; Q03167; 4.
MINT; Q03167; -.
STRING; 9606.ENSP00000212355; -.
iPTMnet; Q03167; -.
PhosphoSitePlus; Q03167; -.
BioMuta; TGFBR3; -.
DMDM; 311033535; -.
MaxQB; Q03167; -.
PaxDb; Q03167; -.
PeptideAtlas; Q03167; -.
PRIDE; Q03167; -.
ProteomicsDB; 58197; -.
ProteomicsDB; 58198; -. [Q03167-2]
Ensembl; ENST00000212355; ENSP00000212355; ENSG00000069702. [Q03167-1]
Ensembl; ENST00000370399; ENSP00000359426; ENSG00000069702. [Q03167-2]
Ensembl; ENST00000465892; ENSP00000432638; ENSG00000069702. [Q03167-2]
Ensembl; ENST00000525962; ENSP00000436127; ENSG00000069702. [Q03167-1]
GeneID; 7049; -.
KEGG; hsa:7049; -.
UCSC; uc001doh.4; human. [Q03167-1]
CTD; 7049; -.
DisGeNET; 7049; -.
EuPathDB; HostDB:ENSG00000069702.10; -.
GeneCards; TGFBR3; -.
H-InvDB; HIX0028622; -.
HGNC; HGNC:11774; TGFBR3.
HPA; CAB018971; -.
HPA; HPA008257; -.
MalaCards; TGFBR3; -.
MIM; 600742; gene.
neXtProt; NX_Q03167; -.
OpenTargets; ENSG00000069702; -.
Orphanet; 231160; Familial cerebral saccular aneurysm.
PharmGKB; PA36487; -.
eggNOG; ENOG410IK7K; Eukaryota.
eggNOG; ENOG410XSMK; LUCA.
GeneTree; ENSGT00530000063861; -.
HOGENOM; HOG000090193; -.
HOVERGEN; HBG057515; -.
InParanoid; Q03167; -.
KO; K05843; -.
OMA; IIENICP; -.
OrthoDB; EOG091G030O; -.
PhylomeDB; Q03167; -.
TreeFam; TF337375; -.
SIGNOR; Q03167; -.
ChiTaRS; TGFBR3; human.
GeneWiki; TGFBR3; -.
GenomeRNAi; 7049; -.
PRO; PR:Q03167; -.
Proteomes; UP000005640; Chromosome 1.
Bgee; ENSG00000069702; Expressed in 231 organ(s), highest expression level in renal glomerulus.
CleanEx; HS_TGFBR3; -.
ExpressionAtlas; Q03167; baseline and differential.
Genevisible; Q03167; HS.
GO; GO:0009986; C:cell surface; ISS:BHF-UCL.
GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
GO; GO:0009897; C:external side of plasma membrane; IDA:BHF-UCL.
GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
GO; GO:0031012; C:extracellular matrix; IEA:Ensembl.
GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
GO; GO:0034673; C:inhibin-betaglycan-ActRII complex; IDA:BHF-UCL.
GO; GO:0005887; C:integral component of plasma membrane; ISS:BHF-UCL.
GO; GO:0043235; C:receptor complex; IDA:BHF-UCL.
GO; GO:0048185; F:activin binding; IEA:Ensembl.
GO; GO:0015026; F:coreceptor activity; IDA:BHF-UCL.
GO; GO:0017134; F:fibroblast growth factor binding; IEA:Ensembl.
GO; GO:0005539; F:glycosaminoglycan binding; ISS:BHF-UCL.
GO; GO:0008201; F:heparin binding; ISS:BHF-UCL.
GO; GO:0030165; F:PDZ domain binding; ISS:BHF-UCL.
GO; GO:0046332; F:SMAD binding; IMP:BHF-UCL.
GO; GO:0050431; F:transforming growth factor beta binding; IDA:BHF-UCL.
GO; GO:0070123; F:transforming growth factor beta receptor activity, type III; IDA:BHF-UCL.
GO; GO:0005160; F:transforming growth factor beta receptor binding; ISS:BHF-UCL.
GO; GO:0005024; F:transforming growth factor beta-activated receptor activity; IDA:BHF-UCL.
GO; GO:0005114; F:type II transforming growth factor beta receptor binding; IDA:BHF-UCL.
GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
GO; GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL.
GO; GO:0060317; P:cardiac epithelial to mesenchymal transition; IDA:BHF-UCL.
GO; GO:0060038; P:cardiac muscle cell proliferation; ISS:BHF-UCL.
GO; GO:0016477; P:cell migration; ISS:BHF-UCL.
GO; GO:0060318; P:definitive erythrocyte differentiation; ISS:BHF-UCL.
GO; GO:0060216; P:definitive hemopoiesis; ISS:BHF-UCL.
GO; GO:0060939; P:epicardium-derived cardiac fibroblast cell development; ISS:BHF-UCL.
GO; GO:0001837; P:epithelial to mesenchymal transition; IDA:BHF-UCL.
GO; GO:0003007; P:heart morphogenesis; ISS:BHF-UCL.
GO; GO:0060347; P:heart trabecula formation; ISS:BHF-UCL.
GO; GO:0061384; P:heart trabecula morphogenesis; ISS:BHF-UCL.
GO; GO:0006955; P:immune response; IMP:BHF-UCL.
GO; GO:0035556; P:intracellular signal transduction; IMP:BHF-UCL.
GO; GO:0001889; P:liver development; ISS:BHF-UCL.
GO; GO:0003150; P:muscular septum morphogenesis; ISS:BHF-UCL.
GO; GO:0051271; P:negative regulation of cellular component movement; IDA:BHF-UCL.
GO; GO:0050680; P:negative regulation of epithelial cell proliferation; ISS:BHF-UCL.
GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
GO; GO:0003151; P:outflow tract morphogenesis; ISS:BHF-UCL.
GO; GO:0060389; P:pathway-restricted SMAD protein phosphorylation; IMP:BHF-UCL.
GO; GO:0060045; P:positive regulation of cardiac muscle cell proliferation; ISS:BHF-UCL.
GO; GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
GO; GO:0043393; P:regulation of protein binding; IEA:Ensembl.
GO; GO:0032354; P:response to follicle-stimulating hormone; IDA:BHF-UCL.
GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
GO; GO:0034699; P:response to luteinizing hormone; IDA:BHF-UCL.
GO; GO:0034695; P:response to prostaglandin E; IDA:BHF-UCL.
GO; GO:0062009; P:secondary palate development; ISS:BHF-UCL.
GO; GO:0007181; P:transforming growth factor beta receptor complex assembly; IEA:Ensembl.
GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:BHF-UCL.
GO; GO:0060979; P:vasculogenesis involved in coronary vascular morphogenesis; ISS:BHF-UCL.
GO; GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; ISS:BHF-UCL.
GO; GO:0003223; P:ventricular compact myocardium morphogenesis; ISS:BHF-UCL.
GO; GO:0060412; P:ventricular septum morphogenesis; ISS:BHF-UCL.
InterPro; IPR001507; ZP_dom.
InterPro; IPR017977; ZP_dom_CS.
Pfam; PF00100; Zona_pellucida; 1.
PRINTS; PR00023; ZPELLUCIDA.
SMART; SM00241; ZP; 1.
PROSITE; PS00682; ZP_1; 1.
PROSITE; PS51034; ZP_2; 1.
1: Evidence at protein level;
Alternative splicing; Cell membrane; Complete proteome;
Disulfide bond; Glycoprotein; Membrane; Polymorphism; Proteoglycan;
Receptor; Reference proteome; Secreted; Signal; Transmembrane;
Transmembrane helix.
SIGNAL 1 20 {ECO:0000255}.
CHAIN 21 851 Transforming growth factor beta receptor
type 3.
/FTId=PRO_0000041663.
TOPO_DOM 21 787 Extracellular. {ECO:0000255}.
TRANSMEM 788 809 Helical. {ECO:0000255}.
TOPO_DOM 810 851 Cytoplasmic. {ECO:0000255}.
DOMAIN 455 730 ZP. {ECO:0000255|PROSITE-
ProRule:PRU00375}.
REGION 737 751 Interaction with TGF-beta ligand.
{ECO:0000250}.
CARBOHYD 141 141 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 492 492 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 534 534 O-linked (Xyl...) (glycosaminoglycan)
serine. {ECO:0000250}.
CARBOHYD 545 545 O-linked (Xyl...) (glycosaminoglycan)
serine. {ECO:0000250}.
CARBOHYD 571 571 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 590 590 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CARBOHYD 697 697 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
DISULFID 639 705 {ECO:0000250}.
DISULFID 660 730 {ECO:0000250}.
DISULFID 710 723 {ECO:0000250}.
VAR_SEQ 359 359 Missing (in isoform 2).
{ECO:0000303|PubMed:1333192}.
/FTId=VSP_040018.
VARIANT 14 14 S -> N (in dbSNP:rs17884205).
{ECO:0000269|Ref.3}.
/FTId=VAR_020891.
VARIANT 15 15 S -> F (in dbSNP:rs1805110).
{ECO:0000269|PubMed:10944857,
ECO:0000269|PubMed:1333192,
ECO:0000269|Ref.3}.
/FTId=VAR_014920.
VARIANT 163 163 W -> L (in dbSNP:rs17885124).
{ECO:0000269|Ref.3}.
/FTId=VAR_020892.
VARIANT 351 351 F -> I (in dbSNP:rs11466592).
/FTId=VAR_057499.
VARIANT 635 635 A -> T (in dbSNP:rs17882578).
{ECO:0000269|Ref.3}.
/FTId=VAR_020893.
VARIANT 765 765 G -> R (in dbSNP:rs17882828).
{ECO:0000269|Ref.3}.
/FTId=VAR_020894.
VARIANT 777 777 P -> S (in dbSNP:rs2228363).
/FTId=VAR_066625.
CONFLICT 89 89 P -> S (in Ref. 4; BAF84034).
{ECO:0000305}.
CONFLICT 238 238 I -> V (in Ref. 4; BAF84034).
{ECO:0000305}.
SEQUENCE 851 AA; 93499 MW; AEC56C4477C003B2 CRC64;
MTSHYVIAIF ALMSSCLATA GPEPGALCEL SPVSASHPVQ ALMESFTVLS GCASRGTTGL
PQEVHVLNLR TAGQGPGQLQ REVTLHLNPI SSVHIHHKSV VFLLNSPHPL VWHLKTERLA
TGVSRLFLVS EGSVVQFSSA NFSLTAETEE RNFPHGNEHL LNWARKEYGA VTSFTELKIA
RNIYIKVGED QVFPPKCNIG KNFLSLNYLA EYLQPKAAEG CVMSSQPQNE EVHIIELITP
NSNPYSAFQV DITIDIRPSQ EDLEVVKNLI LILKCKKSVN WVIKSFDVKG SLKIIAPNSI
GFGKESERSM TMTKSIRDDI PSTQGNLVKW ALDNGYSPIT SYTMAPVANR FHLRLENNAE
EMGDEEVHTI PPELRILLDP GALPALQNPP IRGGEGQNGG LPFPFPDISR RVWNEEGEDG
LPRPKDPVIP SIQLFPGLRE PEEVQGSVDI ALSVKCDNEK MIVAVEKDSF QASGYSGMDV
TLLDPTCKAK MNGTHFVLES PLNGCGTRPR WSALDGVVYY NSIVIQVPAL GDSSGWPDGY
EDLESGDNGF PGDMDEGDAS LFTRPEIVVF NCSLQQVRNP SSFQEQPHGN ITFNMELYNT
DLFLVPSQGV FSVPENGHVY VEVSVTKAEQ ELGFAIQTCF ISPYSNPDRM SHYTIIENIC
PKDESVKFYS PKRVHFPIPQ ADMDKKRFSF VFKPVFNTSL LFLQCELTLC TKMEKHPQKL
PKCVPPDEAC TSLDASIIWA MMQNKKTFTK PLAVIHHEAE SKEKGPSMKE PNPISPPIFH
GLDTLTVMGI AFAAFVIGAL LTGALWYIYS HTGETAGRQQ VPTSPPASEN SSAAHSIGST
QSTPCSSSST A


Related products :

Catalog number Product name Quantity
EIAAB42139 Betaglycan,Homo sapiens,Human,TGF-beta receptor type 3,TGF-beta receptor type III,TGFBR3,TGFR-3,Transforming growth factor beta receptor III,Transforming growth factor beta receptor type 3
EIAAB42137 Betaglycan,Mouse,Mus musculus,TGF-beta receptor type 3,TGF-beta receptor type III,Tgfbr3,TGFR-3,Transforming growth factor beta receptor III,Transforming growth factor beta receptor type 3
EIAAB42140 Betaglycan,Rat,Rattus norvegicus,TGF-beta receptor type 3,TGF-beta receptor type III,Tgfbr3,TGFR-3,Transforming growth factor beta receptor III,Transforming growth factor beta receptor type 3
EIAAB42138 Betaglycan,Pig,Sus scrofa,TGF-beta receptor type 3,TGF-beta receptor type III,TGFBR3,TGFR-3,Transforming growth factor beta receptor III,Transforming growth factor beta receptor type 3
EIAAB42158 Rat,Rattus norvegicus,Serine_threonine-protein kinase receptor R4,SKR4,TbetaR-I,TGF-beta receptor type I,TGF-beta receptor type-1,TGF-beta type I receptor,Tgfbr1,TGFR-1,Transforming growth factor-beta
EIAAB42165 Homo sapiens,Human,TbetaR-II,TGF-beta receptor type II,TGF-beta receptor type-2,TGF-beta type II receptor,TGFBR2,TGFR-2,Transforming growth factor-beta receptor type II
EIAAB42163 Rat,Rattus norvegicus,TbetaR-II,TGF-beta receptor type II,TGF-beta receptor type-2,TGF-beta type II receptor,Tgfbr2,TGFR-2,Transforming growth factor-beta receptor type II
EIAAB42157 Bos taurus,Bovine,TbetaR-I,TGF-beta receptor type I,TGF-beta receptor type-1,TGF-beta type I receptor,TGFBR1,TGFR-1,Transforming growth factor-beta receptor type I
EIAAB42164 Mouse,Mus musculus,TbetaR-II,TGF-beta receptor type II,TGF-beta receptor type-2,TGF-beta type II receptor,Tgfbr2,TGFR-2,Transforming growth factor-beta receptor type II
EIAAB42156 Pig,Sus scrofa,TbetaR-I,TGF-beta receptor type I,TGF-beta receptor type-1,TGF-beta type I receptor,TGFBR1,TGFR-1,Transforming growth factor-beta receptor type I
EIAAB42162 Pig,Sus scrofa,TbetaR-II,TGF-beta receptor type II,TGF-beta receptor type-2,TGF-beta type II receptor,TGFBR2,TGFR-2,Transforming growth factor-beta receptor type II
101-M96 TGFR-1 (ALK-5) Anti-Human Host: Mouse transforming growth factor, beta receptor 1; AAT5; ALK5; MSSE; SKR4; ALK-5; LDS1A; LDS2A; TGFR-1; ACVRLK4;TGF-beta receptor type-1 tbetaR-I; TGF-beta receptor typ 100
EIAAB42159 ESK2,Mouse,Mus musculus,TbetaR-I,TGF-beta receptor type I,TGF-beta receptor type-1,Tgfbr1,TGFR-1,Transforming growth factor-beta receptor type I
EIAAB42161 Chicken,Gallus gallus,TbetaR-II,TGF-beta receptor type II,TGF-beta receptor type-2,TGF-beta type II receptor,TGFBR2,TGFR-2,Transforming growth factor-beta receptor type II
101-M96 TGFR-1 (ALK-5), Host: Mouse, Species: Anti-Human, Synonyms: transforming growth factor, beta receptor 1; AAT5; ALK5; SKR4; LDS1A; LDS2A; TGFR-1; TGF-beta receptor type-1 100 ug
18-272-195253 TGFBR2 - Goat polyclonal to TGFBR2; EC 2.7.11.30; TGF-beta receptor type II; TGFR-2; TGF-beta type II receptor; Transforming growth factor-beta receptor type II; TbetaR-II Polyclonal 0.05 mg
18-272-195254 TGFBR3 - Goat polyclonal to TGFBR3; TGFR-3; Transforming growth factor beta receptor III; Betaglycan Polyclonal 0.05 mg
CSB-EL023453RA Rat Transforming growth factor beta receptor type 3(TGFBR3) ELISA kit 96T
H7659 Transforming growth factor beta receptor type 3 (TGFBR3), Rat, ELISA Kit 96T
H7658 Transforming growth factor beta receptor type 3 (TGFBR3), Pig, ELISA Kit 96T
CSB-EL023453PI Pig Transforming growth factor beta receptor type 3(TGFBR3) ELISA kit SpeciesPig 96T
CSB-EL023453MO Mouse Transforming growth factor beta receptor type 3(TGFBR3) ELISA kit 96T
CSB-EL023453RA Rat Transforming growth factor beta receptor type 3(TGFBR3) ELISA kit SpeciesRat 96T
H7656 Transforming growth factor beta receptor type 3 (TGFBR3), Human, ELISA Kit 96T
H7657 Transforming growth factor beta receptor type 3 (TGFBR3), Mouse, ELISA Kit 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur